Structure

Physi-Chem Properties

Molecular Weight:  454.34
Volume:  509.035
LogP:  7.139
LogD:  4.696
LogS:  -4.472
# Rotatable Bonds:  5
TPSA:  54.37
# H-Bond Aceptor:  3
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.432
Synthetic Accessibility Score:  4.655
Fsp3:  0.8
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.332
MDCK Permeability:  1.1538352737261448e-05
Pgp-inhibitor:  0.36
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.022
20% Bioavailability (F20%):  0.794
30% Bioavailability (F30%):  0.968

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.163
Plasma Protein Binding (PPB):  92.14873504638672%
Volume Distribution (VD):  0.945
Pgp-substrate:  2.2993555068969727%

ADMET: Metabolism

CYP1A2-inhibitor:  0.018
CYP1A2-substrate:  0.464
CYP2C19-inhibitor:  0.047
CYP2C19-substrate:  0.942
CYP2C9-inhibitor:  0.163
CYP2C9-substrate:  0.933
CYP2D6-inhibitor:  0.007
CYP2D6-substrate:  0.046
CYP3A4-inhibitor:  0.205
CYP3A4-substrate:  0.784

ADMET: Excretion

Clearance (CL):  19.0
Half-life (T1/2):  0.111

ADMET: Toxicity

hERG Blockers:  0.033
Human Hepatotoxicity (H-HT):  0.634
Drug-inuced Liver Injury (DILI):  0.034
AMES Toxicity:  0.006
Rat Oral Acute Toxicity:  0.236
Maximum Recommended Daily Dose:  0.537
Skin Sensitization:  0.06
Carcinogencity:  0.732
Eye Corrosion:  0.005
Eye Irritation:  0.058
Respiratory Toxicity:  0.965

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC38350

Natural Product ID:  NPC38350
Common Name*:   Beta-Elemonic Acid
IUPAC Name:   (2S)-6-methyl-2-[(5S,10S,13S,14S,17R)-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,7,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]hept-5-enoic acid
Synonyms:   Beta-Elemonic Acid
Standard InCHIKey:  XLPAINGDLCDYQV-DXXDIINSSA-N
Standard InCHI:  InChI=1S/C30H46O3/c1-19(2)9-8-10-20(26(32)33)21-13-17-30(7)23-11-12-24-27(3,4)25(31)15-16-28(24,5)22(23)14-18-29(21,30)6/h9,20-21,24H,8,10-18H2,1-7H3,(H,32,33)/t20-,21+,24+,28+,29-,30+/m0/s1
SMILES:  CC(=CCC[C@@H]([C@H]1CC[C@]2([C@@]1(C)CCC1=C2CC[C@H]2[C@]1(C)CCC(=O)C2(C)C)C)C(=O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL566929
PubChem CID:   24721570
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO10628 Boswellia papyrifera Species Burseraceae Eukaryota n.a. n.a. n.a. PMID[15730241]
NPO33055 boswellia spp. Species Burseraceae Eukaryota n.a. n.a. n.a. PMID[24844534]
NPO10628 Boswellia papyrifera Species Burseraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1591 Individual Protein Prolyl endopeptidase Homo sapiens IC50 = 39740.0 nM PMID[512648]
NPT540 Individual Protein Bile acid receptor FXR Homo sapiens EC50 = 0.0 nM PMID[512649]
NPT324 Individual Protein Cyclooxygenase-1 Ovis aries Activity = 81.1 % PMID[512650]
NPT31 Individual Protein Cyclooxygenase-2 Homo sapiens Activity = 70.1 % PMID[512650]
NPT324 Individual Protein Cyclooxygenase-1 Ovis aries IC50 > 10000.0 nM PMID[512650]
NPT31 Individual Protein Cyclooxygenase-2 Homo sapiens IC50 > 10000.0 nM PMID[512650]
NPT745 Individual Protein G-protein coupled bile acid receptor 1 Homo sapiens EC50 > 10000.0 nM PMID[512649]
NPT745 Individual Protein G-protein coupled bile acid receptor 1 Homo sapiens Efficacy = 0.0 % PMID[512649]
NPT956 Individual Protein Prostaglandin E synthase Homo sapiens Activity = 16.7 % PMID[512650]
NPT956 Individual Protein Prostaglandin E synthase Homo sapiens IC50 = 900.0 nM PMID[512650]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC38350 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC201912
0.9868 High Similarity NPC260956
0.974 High Similarity NPC69279
0.974 High Similarity NPC83569
0.9737 High Similarity NPC147066
0.9733 High Similarity NPC477371
0.9481 High Similarity NPC477372
0.9359 High Similarity NPC133391
0.9359 High Similarity NPC320514
0.925 High Similarity NPC29447
0.9241 High Similarity NPC168188
0.9241 High Similarity NPC470015
0.9241 High Similarity NPC477373
0.9024 High Similarity NPC187376
0.9024 High Similarity NPC159046
0.9024 High Similarity NPC233836
0.9024 High Similarity NPC96496
0.9024 High Similarity NPC136948
0.9012 High Similarity NPC311702
0.9012 High Similarity NPC123319
0.9012 High Similarity NPC94531
0.8974 High Similarity NPC215843
0.8974 High Similarity NPC196827
0.8974 High Similarity NPC274996
0.8974 High Similarity NPC158846
0.8902 High Similarity NPC155011
0.8902 High Similarity NPC28252
0.8902 High Similarity NPC55309
0.8889 High Similarity NPC165064
0.8889 High Similarity NPC473246
0.8831 High Similarity NPC309399
0.8824 High Similarity NPC204341
0.881 High Similarity NPC77168
0.881 High Similarity NPC474570
0.881 High Similarity NPC262043
0.881 High Similarity NPC54689
0.881 High Similarity NPC102414
0.881 High Similarity NPC84271
0.88 High Similarity NPC160817
0.8795 High Similarity NPC474684
0.8795 High Similarity NPC142361
0.878 High Similarity NPC473038
0.878 High Similarity NPC11711
0.878 High Similarity NPC474083
0.8765 High Similarity NPC477852
0.8765 High Similarity NPC167103
0.8765 High Similarity NPC310470
0.875 High Similarity NPC278459
0.875 High Similarity NPC274050
0.875 High Similarity NPC263272
0.875 High Similarity NPC162632
0.875 High Similarity NPC267691
0.875 High Similarity NPC471898
0.8734 High Similarity NPC231431
0.8734 High Similarity NPC192744
0.8721 High Similarity NPC66429
0.8721 High Similarity NPC152897
0.8718 High Similarity NPC165711
0.8718 High Similarity NPC471899
0.8718 High Similarity NPC66105
0.8718 High Similarity NPC107039
0.8718 High Similarity NPC471897
0.8706 High Similarity NPC111585
0.8706 High Similarity NPC175628
0.8706 High Similarity NPC148414
0.8701 High Similarity NPC192540
0.8701 High Similarity NPC279666
0.869 High Similarity NPC242864
0.8659 High Similarity NPC85774
0.8659 High Similarity NPC209882
0.8659 High Similarity NPC59453
0.8659 High Similarity NPC221758
0.8659 High Similarity NPC82902
0.8659 High Similarity NPC214043
0.8659 High Similarity NPC164577
0.8642 High Similarity NPC251779
0.8642 High Similarity NPC3511
0.8642 High Similarity NPC327969
0.8642 High Similarity NPC193347
0.8642 High Similarity NPC142253
0.8642 High Similarity NPC240302
0.8642 High Similarity NPC69101
0.8642 High Similarity NPC296367
0.8642 High Similarity NPC321289
0.8625 High Similarity NPC37038
0.8608 High Similarity NPC260385
0.8608 High Similarity NPC321514
0.8608 High Similarity NPC74410
0.8608 High Similarity NPC179028
0.8608 High Similarity NPC110094
0.8608 High Similarity NPC280654
0.8605 High Similarity NPC297265
0.8605 High Similarity NPC154101
0.8605 High Similarity NPC26888
0.859 High Similarity NPC20466
0.859 High Similarity NPC69143
0.859 High Similarity NPC180886
0.859 High Similarity NPC246445
0.859 High Similarity NPC89294
0.8588 High Similarity NPC475921
0.8588 High Similarity NPC474889
0.8588 High Similarity NPC474704
0.8571 High Similarity NPC183503
0.8571 High Similarity NPC241854
0.8571 High Similarity NPC283908
0.8571 High Similarity NPC251970
0.8571 High Similarity NPC312215
0.8571 High Similarity NPC167877
0.8571 High Similarity NPC301065
0.8571 High Similarity NPC161923
0.8571 High Similarity NPC103958
0.8571 High Similarity NPC476046
0.8554 High Similarity NPC470223
0.8554 High Similarity NPC469948
0.8554 High Similarity NPC474218
0.8554 High Similarity NPC269638
0.8554 High Similarity NPC471224
0.8554 High Similarity NPC474537
0.8537 High Similarity NPC70834
0.8537 High Similarity NPC97913
0.8523 High Similarity NPC171395
0.8523 High Similarity NPC263347
0.8519 High Similarity NPC142244
0.8506 High Similarity NPC206810
0.8506 High Similarity NPC243866
0.85 High Similarity NPC199595
0.85 High Similarity NPC16394
0.85 High Similarity NPC472490
0.8488 Intermediate Similarity NPC469400
0.8488 Intermediate Similarity NPC471896
0.8481 Intermediate Similarity NPC212661
0.8481 Intermediate Similarity NPC68828
0.8481 Intermediate Similarity NPC471035
0.8471 Intermediate Similarity NPC294480
0.8471 Intermediate Similarity NPC471722
0.8452 Intermediate Similarity NPC212843
0.8452 Intermediate Similarity NPC474732
0.8452 Intermediate Similarity NPC51014
0.8452 Intermediate Similarity NPC89077
0.8452 Intermediate Similarity NPC94755
0.8452 Intermediate Similarity NPC31564
0.8452 Intermediate Similarity NPC474778
0.8452 Intermediate Similarity NPC118648
0.8452 Intermediate Similarity NPC474733
0.8452 Intermediate Similarity NPC72133
0.8452 Intermediate Similarity NPC145879
0.8452 Intermediate Similarity NPC475022
0.8452 Intermediate Similarity NPC469994
0.8452 Intermediate Similarity NPC222613
0.8442 Intermediate Similarity NPC161187
0.8442 Intermediate Similarity NPC244708
0.8442 Intermediate Similarity NPC330659
0.8434 Intermediate Similarity NPC194937
0.8434 Intermediate Similarity NPC472865
0.8434 Intermediate Similarity NPC237712
0.8434 Intermediate Similarity NPC144258
0.8434 Intermediate Similarity NPC87552
0.8434 Intermediate Similarity NPC96095
0.8434 Intermediate Similarity NPC476038
0.8434 Intermediate Similarity NPC320801
0.8427 Intermediate Similarity NPC472941
0.8427 Intermediate Similarity NPC456
0.8427 Intermediate Similarity NPC155676
0.8415 Intermediate Similarity NPC100297
0.8415 Intermediate Similarity NPC472239
0.8415 Intermediate Similarity NPC151519
0.8409 Intermediate Similarity NPC469406
0.8409 Intermediate Similarity NPC166906
0.8395 Intermediate Similarity NPC104545
0.8395 Intermediate Similarity NPC26139
0.8395 Intermediate Similarity NPC472478
0.8391 Intermediate Similarity NPC86266
0.8391 Intermediate Similarity NPC23434
0.8391 Intermediate Similarity NPC212301
0.8391 Intermediate Similarity NPC110657
0.8391 Intermediate Similarity NPC189520
0.8375 Intermediate Similarity NPC469996
0.8375 Intermediate Similarity NPC321690
0.8375 Intermediate Similarity NPC82635
0.8372 Intermediate Similarity NPC86319
0.8372 Intermediate Similarity NPC215029
0.8372 Intermediate Similarity NPC275740
0.8372 Intermediate Similarity NPC214387
0.8372 Intermediate Similarity NPC476733
0.8354 Intermediate Similarity NPC899
0.8353 Intermediate Similarity NPC128644
0.8353 Intermediate Similarity NPC317590
0.8353 Intermediate Similarity NPC93778
0.8353 Intermediate Similarity NPC58063
0.8353 Intermediate Similarity NPC90652
0.8353 Intermediate Similarity NPC475740
0.8353 Intermediate Similarity NPC136548
0.8333 Intermediate Similarity NPC142649
0.8333 Intermediate Similarity NPC283733
0.8333 Intermediate Similarity NPC8571
0.8315 Intermediate Similarity NPC174948
0.8315 Intermediate Similarity NPC469599
0.8315 Intermediate Similarity NPC317586
0.8315 Intermediate Similarity NPC222845
0.8315 Intermediate Similarity NPC45324

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC38350 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8659 High Similarity NPD4786 Approved
0.8642 High Similarity NPD4223 Phase 3
0.8642 High Similarity NPD4221 Approved
0.8605 High Similarity NPD5281 Approved
0.8605 High Similarity NPD5284 Approved
0.8554 High Similarity NPD5329 Approved
0.8506 High Similarity NPD6399 Phase 3
0.8452 Intermediate Similarity NPD5690 Phase 2
0.8452 Intermediate Similarity NPD4694 Approved
0.8452 Intermediate Similarity NPD5280 Approved
0.8452 Intermediate Similarity NPD6098 Approved
0.8434 Intermediate Similarity NPD4197 Approved
0.8415 Intermediate Similarity NPD3667 Approved
0.8315 Intermediate Similarity NPD5695 Phase 3
0.8293 Intermediate Similarity NPD4692 Approved
0.8293 Intermediate Similarity NPD4139 Approved
0.8256 Intermediate Similarity NPD5737 Approved
0.8256 Intermediate Similarity NPD6672 Approved
0.8235 Intermediate Similarity NPD4689 Approved
0.8235 Intermediate Similarity NPD5279 Phase 3
0.8235 Intermediate Similarity NPD7521 Approved
0.8235 Intermediate Similarity NPD6684 Approved
0.8235 Intermediate Similarity NPD4690 Approved
0.8235 Intermediate Similarity NPD6409 Approved
0.8235 Intermediate Similarity NPD4693 Phase 3
0.8235 Intermediate Similarity NPD4688 Approved
0.8235 Intermediate Similarity NPD5205 Approved
0.8235 Intermediate Similarity NPD5330 Approved
0.8235 Intermediate Similarity NPD7146 Approved
0.8235 Intermediate Similarity NPD7334 Approved
0.8235 Intermediate Similarity NPD4138 Approved
0.8214 Intermediate Similarity NPD3665 Phase 1
0.8214 Intermediate Similarity NPD3666 Approved
0.8214 Intermediate Similarity NPD3133 Approved
0.8182 Intermediate Similarity NPD6050 Approved
0.8161 Intermediate Similarity NPD6904 Approved
0.8161 Intermediate Similarity NPD5328 Approved
0.8161 Intermediate Similarity NPD6673 Approved
0.8161 Intermediate Similarity NPD6080 Approved
0.8148 Intermediate Similarity NPD3617 Approved
0.8132 Intermediate Similarity NPD6083 Phase 2
0.8132 Intermediate Similarity NPD6084 Phase 2
0.8101 Intermediate Similarity NPD5733 Approved
0.8068 Intermediate Similarity NPD5692 Phase 3
0.8068 Intermediate Similarity NPD5207 Approved
0.8046 Intermediate Similarity NPD5208 Approved
0.8046 Intermediate Similarity NPD6903 Approved
0.8046 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.8023 Intermediate Similarity NPD3618 Phase 1
0.7978 Intermediate Similarity NPD6079 Approved
0.7978 Intermediate Similarity NPD5694 Approved
0.7955 Intermediate Similarity NPD4753 Phase 2
0.7955 Intermediate Similarity NPD7285 Clinical (unspecified phase)
0.7949 Intermediate Similarity NPD4747 Approved
0.7907 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7875 Intermediate Similarity NPD4687 Approved
0.7865 Intermediate Similarity NPD4096 Approved
0.7849 Intermediate Similarity NPD5696 Approved
0.7848 Intermediate Similarity NPD5276 Approved
0.7848 Intermediate Similarity NPD4243 Approved
0.7831 Intermediate Similarity NPD4195 Approved
0.7821 Intermediate Similarity NPD4137 Phase 3
0.7816 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD3668 Phase 3
0.7778 Intermediate Similarity NPD5693 Phase 1
0.7778 Intermediate Similarity NPD7515 Phase 2
0.7766 Intermediate Similarity NPD6404 Discontinued
0.7738 Intermediate Similarity NPD4695 Discontinued
0.7722 Intermediate Similarity NPD4691 Approved
0.7717 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD3621 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD4202 Approved
0.7692 Intermediate Similarity NPD5133 Approved
0.7674 Intermediate Similarity NPD4788 Approved
0.7662 Intermediate Similarity NPD4224 Phase 2
0.7654 Intermediate Similarity NPD4784 Approved
0.7654 Intermediate Similarity NPD4785 Approved
0.764 Intermediate Similarity NPD4518 Approved
0.7625 Intermediate Similarity NPD6081 Approved
0.7614 Intermediate Similarity NPD4519 Discontinued
0.7614 Intermediate Similarity NPD4623 Approved
0.7609 Intermediate Similarity NPD6001 Approved
0.7609 Intermediate Similarity NPD7748 Approved
0.7561 Intermediate Similarity NPD7339 Approved
0.7561 Intermediate Similarity NPD6942 Approved
0.7551 Intermediate Similarity NPD6675 Approved
0.7551 Intermediate Similarity NPD6402 Approved
0.7551 Intermediate Similarity NPD7128 Approved
0.7551 Intermediate Similarity NPD5739 Approved
0.7527 Intermediate Similarity NPD5210 Approved
0.7527 Intermediate Similarity NPD4629 Approved
0.7527 Intermediate Similarity NPD5654 Approved
0.75 Intermediate Similarity NPD5784 Clinical (unspecified phase)
0.7447 Intermediate Similarity NPD4697 Phase 3
0.7447 Intermediate Similarity NPD5221 Approved
0.7447 Intermediate Similarity NPD7614 Phase 1
0.7447 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7447 Intermediate Similarity NPD5222 Approved
0.7439 Intermediate Similarity NPD4058 Approved
0.74 Intermediate Similarity NPD6881 Approved
0.74 Intermediate Similarity NPD7320 Approved
0.74 Intermediate Similarity NPD6899 Approved
0.7391 Intermediate Similarity NPD8034 Phase 2
0.7391 Intermediate Similarity NPD8035 Phase 2
0.7368 Intermediate Similarity NPD5959 Approved
0.7368 Intermediate Similarity NPD7902 Approved
0.7368 Intermediate Similarity NPD5173 Approved
0.7368 Intermediate Similarity NPD4755 Approved
0.7349 Intermediate Similarity NPD5275 Approved
0.7349 Intermediate Similarity NPD4190 Phase 3
0.7333 Intermediate Similarity NPD3573 Approved
0.7327 Intermediate Similarity NPD6373 Approved
0.7327 Intermediate Similarity NPD6372 Approved
0.73 Intermediate Similarity NPD5701 Approved
0.73 Intermediate Similarity NPD5697 Approved
0.7262 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.7255 Intermediate Similarity NPD7102 Approved
0.7255 Intermediate Similarity NPD7290 Approved
0.7255 Intermediate Similarity NPD6883 Approved
0.725 Intermediate Similarity NPD5360 Phase 3
0.725 Intermediate Similarity NPD5361 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.7228 Intermediate Similarity NPD6011 Approved
0.7216 Intermediate Similarity NPD5286 Approved
0.7216 Intermediate Similarity NPD5285 Approved
0.7216 Intermediate Similarity NPD4700 Approved
0.7216 Intermediate Similarity NPD4696 Approved
0.7204 Intermediate Similarity NPD6411 Approved
0.7184 Intermediate Similarity NPD6649 Approved
0.7184 Intermediate Similarity NPD6617 Approved
0.7184 Intermediate Similarity NPD6847 Approved
0.7184 Intermediate Similarity NPD6650 Approved
0.7184 Intermediate Similarity NPD8130 Phase 1
0.7184 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7184 Intermediate Similarity NPD6869 Approved
0.7172 Intermediate Similarity NPD6052 Approved
0.7157 Intermediate Similarity NPD6012 Approved
0.7157 Intermediate Similarity NPD6013 Approved
0.7157 Intermediate Similarity NPD6014 Approved
0.7143 Intermediate Similarity NPD5223 Approved
0.7126 Intermediate Similarity NPD7525 Registered
0.7115 Intermediate Similarity NPD8297 Approved
0.7115 Intermediate Similarity NPD6882 Approved
0.7113 Intermediate Similarity NPD7638 Approved
0.7089 Intermediate Similarity NPD3171 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD4789 Approved
0.7071 Intermediate Similarity NPD5211 Phase 2
0.7071 Intermediate Similarity NPD4633 Approved
0.7071 Intermediate Similarity NPD5225 Approved
0.7071 Intermediate Similarity NPD5091 Approved
0.7071 Intermediate Similarity NPD5226 Approved
0.7071 Intermediate Similarity NPD5224 Approved
0.7059 Intermediate Similarity NPD6117 Approved
0.7053 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7053 Intermediate Similarity NPD7900 Approved
0.7041 Intermediate Similarity NPD7639 Approved
0.7041 Intermediate Similarity NPD7640 Approved
0.7024 Intermediate Similarity NPD6924 Approved
0.7024 Intermediate Similarity NPD6926 Approved
0.7 Intermediate Similarity NPD4754 Approved
0.7 Intermediate Similarity NPD5174 Approved
0.7 Intermediate Similarity NPD5175 Approved
0.7 Intermediate Similarity NPD7331 Phase 2
0.6989 Remote Similarity NPD6051 Approved
0.6989 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6989 Remote Similarity NPD6101 Approved
0.6988 Remote Similarity NPD4809 Clinical (unspecified phase)
0.6988 Remote Similarity NPD4808 Clinical (unspecified phase)
0.6977 Remote Similarity NPD6116 Phase 1
0.6966 Remote Similarity NPD4752 Clinical (unspecified phase)
0.6961 Remote Similarity NPD6614 Approved
0.6961 Remote Similarity NPD6412 Phase 2
0.6941 Remote Similarity NPD3702 Approved
0.6932 Remote Similarity NPD5368 Approved
0.6931 Remote Similarity NPD5141 Approved
0.6916 Remote Similarity NPD6868 Approved
0.6907 Remote Similarity NPD7732 Phase 3
0.6897 Remote Similarity NPD6114 Approved
0.6897 Remote Similarity NPD6697 Approved
0.6897 Remote Similarity NPD6115 Approved
0.6897 Remote Similarity NPD6118 Approved
0.6889 Remote Similarity NPD3527 Clinical (unspecified phase)
0.6889 Remote Similarity NPD5362 Discontinued
0.6887 Remote Similarity NPD4632 Approved
0.6875 Remote Similarity NPD7341 Phase 2
0.6867 Remote Similarity NPD4245 Approved
0.6867 Remote Similarity NPD4244 Approved
0.6863 Remote Similarity NPD4767 Approved
0.6863 Remote Similarity NPD4768 Approved
0.6863 Remote Similarity NPD6008 Approved
0.686 Remote Similarity NPD6933 Approved
0.6854 Remote Similarity NPD5369 Approved
0.6852 Remote Similarity NPD7115 Discovery
0.6789 Remote Similarity NPD6335 Approved
0.6786 Remote Similarity NPD4758 Discontinued
0.6786 Remote Similarity NPD5777 Approved
0.6778 Remote Similarity NPD4270 Approved
0.6778 Remote Similarity NPD4269 Approved
0.6778 Remote Similarity NPD6435 Approved
0.6759 Remote Similarity NPD6274 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data